Protected intake, payment, prescribing, and care enrollment reopen in September.

Do PCOS Cysts Go Away? What They Really Are

Jul 23, 2026 · 3 min readRolf Hoefer, Ph.D.

3 sources reviewedMedically reviewed by Amy Bingaman, MD, MSCP, FACOGArticle updated Jul 23, 2026Our editorial process

The short answer

The "cysts" in PCOS are not true cysts; they are small immature follicles, and about one in five women with the condition do not have them on ultrasound at all. The misunderstanding was a main reason the condition was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026. [2] After menopause, ovulation and periods stop, so the polycystic-ovary pattern fades, but the condition itself does not go away: insulin resistance, higher androgens, and metabolic risk persist and cardiovascular risk rises. [3] So the "cysts" become less relevant with age, while the metabolic side needs ongoing attention. [3]

What you’ll learn

  • PCOS "cysts" are actually small immature follicles, not true cysts, and about one in five women with the condition do not have them at all.
  • That misunderstanding helped drive the 2026 rename to PMOS (polyendocrine metabolic ovarian syndrome). [2]
  • After menopause, ovulation stops and the polycystic-ovary pattern fades, but the condition does not disappear. [3]
  • Insulin resistance, higher androgens, and metabolic and cardiovascular risk persist and even rise after menopause. [3]
  • Any bleeding after menopause is a separate warning sign that should be checked, because the condition raises endometrial cancer risk. [3]

"Do PCOS cysts go away?" is a reasonable question about the condition, with a surprising answer: the "cysts" were not quite what the name implied.

In PCOS the ovaries contain many small immature follicles, not true fluid-filled cysts, and about one in five women with the condition do not have that appearance on ultrasound at all. That misunderstanding, reducing a complex hormonal and metabolic disorder to a story about cysts, was a main reason the condition was formally renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026. [2]

The gap worth naming is between "the cysts" and "the condition." One can fade with age while the other does not.

What the "cysts" actually are

The follicles seen on a polycystic ovary are eggs that started to develop but stalled, not the large fluid-filled cysts people picture. They are a sign of the underlying hormonal pattern, not the disease itself, which is why removing focus from them was part of the rename. [2] This matters because it reframes PCOS as a metabolic and endocrine condition rather than an ovary problem.

What happens after menopause

After menopause, ovulation and periods stop. The polycystic-ovary pattern fades, so in that narrow sense the "cysts" do go away. [3] But the condition does not: insulin resistance and higher androgens usually persist, and the metabolic and cardiovascular effects can actually intensify. High blood pressure, high cholesterol, and cardiovascular disease risk rise significantly, and endometrial cancer risk is elevated. [3]

Article table: Feature, After menopause
FeatureAfter menopause
Polycystic-ovary appearanceFades as ovulation and periods stop [3]
Insulin resistanceUsually persists [3]
Higher androgens (hair, acne)Tend to stay [3]
Cardiovascular and diabetes riskRises with age [3]

One honest note: the evidence is limited for long-term outcomes in older women, but the pattern is consistent: reproductive features ease while metabolic risk continues.

Why the fading pattern can mislead

The practical implication is that care should not wind down when periods stop. Because insulin resistance, higher androgens, and cardiovascular risk carry forward, the 2023 international guideline for the condition recommends continued metabolic screening, including blood glucose, blood pressure, and cholesterol, well into the postmenopausal years. [1] In other words, the reassuring half of the answer, that the cyst pattern fades, can be misleading if it is read as an all-clear. The part of the condition that most affects long-term health is exactly the part that does not go away, so ongoing monitoring is what protects the years ahead. [1]

When something needs a clinician

Most of this is a gradual metabolic story, but one thing is not: bleeding after menopause. Because the condition raises endometrial cancer risk, any post-menopausal bleeding is a warning sign that should be checked promptly rather than assumed to be hormonal. [3] For related detail, see ultrasound and the condition and cardiovascular risk after menopause.

Who this fits

This fits women who were told they have "ovarian cysts" from PCOS and want to understand what happens over time. It is not a fit for assuming that a fading cyst pattern means the condition is cured, or for treating post-menopausal bleeding as normal. Those need a clinician.

What to ask your clinician

  1. Do my ovaries show the follicle pattern of the condition, and does that change anything now?
  2. Since the metabolic side persists, what glucose, blood pressure, and cholesterol screening should I have?
  3. Are my androgen-related symptoms worth treating after menopause?
  4. What symptoms, such as bleeding after menopause, should prompt an evaluation?

Bottom line

PCOS "cysts" are small immature follicles, not true cysts, and about one in five women with the condition did not have them, which helped drive the 2026 rename to PMOS. [2] After menopause the polycystic-ovary pattern fades, but the condition does not: insulin resistance, androgens, and metabolic and heart risk persist, so screening continues, and any post-menopausal bleeding should be checked. [3]

References

[1] Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43-G64. doi:10.1093/ejendo/lvad096 https://pubmed.ncbi.nlm.nih.gov/37580861/

[2] American Society for Reproductive Medicine. PCOS is now PMOS: understanding the name change. 2026. https://www.asrm.org/news-and-events/asrm-news/latest-news/may-27-2026-pcos-is-now-pmos-understanding-the-name-change/

[3] Harvard Health Publishing. How PMOS (once called PCOS) affects women after menopause. 2026. https://www.health.harvard.edu/womens-health/how-pmos-once-called-pcos-affects-women-after-menopause

Common questions

Are PCOS cysts real cysts?

No. They are small immature follicles rather than true fluid-filled cysts, and about one in five women with the condition do not have them on ultrasound. That misnomer helped drive the 2026 rename to PMOS. [2][2]

Do PCOS cysts go away after menopause?

The polycystic-ovary pattern fades once ovulation and periods stop, so the "cysts" become less relevant. But the condition itself does not go away. [3][3]

Does PCOS go away after menopause?

No. Insulin resistance, higher androgens, and metabolic and cardiovascular risk persist and can rise after menopause, even as reproductive features ease. [3][3]

Should I still be screened for PCOS after menopause?

Yes. Because metabolic and heart risk continue, clinicians screen glucose, blood pressure, and cholesterol, and any post-menopausal bleeding should be evaluated. [1] [3][1][3]

Related in Weight loss & metabolic health

Insulin resistance & prediabetesBerberine vs Metformin: What the Evidence Actually ShowsHead-to-head, the evidence is thinner than the marketing suggests. In the main direct trial (36 adults with new type 2 diabetes), berberine (0.5 g three times daily) lowered A1c (hemoglobin A1c) and blood glucose about as much as metformin over three months. [1] A polycystic ovary syndrome (PCOS) network meta-analysis found only two small, low-quality head-to-head trials comparing them directly. [2] Metformin is FDA-approved with decades of safety data; berberine is an unregulated supplement that interacts with many medicines and is likely unsafe in pregnancy. [3] [4] Which one fits you is a clinician's call, not a supplement-aisle default.Jul 23, 2026 · 6 min readGLP-1 medicationsDoes Compounded Semaglutide Need to Be Refrigerated?Compounded semaglutide often needs cold-chain handling, but the safe answer comes from the pharmacy label and instructions for that exact compounded product. FDA says injectable glucagon-like peptide-1 drugs require refrigeration as indicated in their package inserts and warns not to use injectable glucagon-like peptide-1 drugs that arrive warm or with insufficient refrigeration. FDA-approved Wegovy and Ozempic labels list specific refrigerator, room-temperature, light, freezing, and day limits, but those branded-label rules should not be copied onto every compounded vial without confirmation from the prescriber or compounder. [1] [2] [3]Jun 24, 2026 · 8 min readGLP-1 medicationsDoes Insurance Cover GLP-1 Weight-Loss Medication?Insurance can cover a glucagon-like peptide-1 medicine for weight loss, but coverage depends on the plan, product, indication, and prior authorization. As of July 1, 2026, Medicare has a temporary glucagon-like peptide-1 Bridge for eligible Part D beneficiaries using certain products for weight management, while other glucagon-like peptide-1 indications may run through ordinary Part D coverage. Commercial and Marketplace plans depend on formulary rules. Before paying cash, ask the plan and prescriber which diagnosis, product, dose form, prior authorization, and appeal path apply. [1] [2] [5]Jun 30, 2026 · 7 min readInsulin resistance & prediabetesDoes PCOS Cause Infertility? What the Evidence SaysYes, but not permanently for most women. Polycystic ovary syndrome (PCOS), recently renamed polyendocrine metabolic ovarian syndrome (PMOS), is the most common cause of anovulation and a leading cause of infertility, because hormonal imbalance keeps the ovary from releasing an egg regularly. [1] The important word is treatable: many women with the condition still conceive, and medicines that restore ovulation work well. In the largest head-to-head trial, letrozole led to a live birth in 27.5% of women versus 19.1% on clomiphene. [4] So PCOS disrupts fertility, but for most it is a condition to manage with a clinician, not a verdict. [2] [3]Jul 23, 2026 · 5 min read